24.04.2012 • News

Celanese Quarterly Profit up 29%

Celanese said that its quarterly profit rose 29% due to strong sales of chemicals used to make glues and fibers.

For the first quarter, the company posted net income of $183 million, or $1.15 per share, compared with $142 million, or 91 cents per share, in the year-earlier period.

Sales rose 2.8% to $1.63 billion.

On Monday night Celanese raised its quarterly dividend 25 % to 7.5 cents.

The results are the first since Mark Rohr became chief executive of Celanese on April 1. Rohr told Reuters he intends to focus on new product areas.

In a statement on Tuesday, Rohr said he expects "challenging market conditions" to continue in Europe and everywhere in Asia except for China.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.